J Diabetes Sci Technol. 2012 Sep 1;6(5):1038-44.
Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions.
Rasouli N, Seggelke S, Gibbs J, Hawkins RM, Casciano ML, Cohlmia E, Taylor-Cousar J, Wang C, Pereira R, Hsia E, Draznin B.
J Clin Endocrinol Metab. 2012 Sep;97(9):3132-7. doi: 10.1210/jc.2012-1244. Epub 2012 Jun 8.
Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Low CC, Draznin B. Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocr Pract. 2013 Dec 10;:1-12. [Epub ahead of print] PubMed PMID: 24326004
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional Care Clinic for Uninsured and Medicaid-Covered Patients with Diabetes Melletis Discharged fFrom the Hospital: A pilot Quality Improvement Study. Hospital Practice; 2014 Feb; 42(1):46-51
Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract. 2014 Dec 1;20(12):1303-8. PubMed PMID: 25100383
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014 Jun;20(6):536-9. PubMed PMID: 24326004
Hawkins RM, Draznin B. Glycemic Control in a Patient with Type 1 Diabetes and Severe Burns. In Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, 2015, p. 204-207
Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract. 2016 Dec;22(12):1401-1405. PubMed PMID: 27540884
Seggleke, S. and Hawkins, RM. (2020). Inpatient Management of Diabetes and Hyperglycemia. In: M. McDermott, ed., Endocrine Secrets, 7th ed. St. Louis: Elsevier, pp.61-66.
1) Hawkins RM, Seggelke S, Gibbs J, Lindsay M, Low Wang CC. Glycemic Control in Hospitalized Patients Receiving Enteral Nutrition. American Diabetes Association 81st Scientific Sessions 2021 (virtual). Poster #2021-A-5827-Diabetes. Diabetes 2021;70(Supplement 1):825-P. https://doi.org/10.2337/db21-825-P.
Transient Severe Insulin Resistance in COVID-19 and Prediabetes in Diabetes in Practice Case Studies with Commentary Hawkins RM, Adair W, Gibbs J, Vinh J, Low Wang C